Cherington Charles's Form 4 filing
Comera Life Sciences Holdings, Inc.CMRA · filed Sep 11, 2023
- Accession no.
- 0001104659-23-099800
- Filed
- Sep 11, 2023
- Trade date
- Sep 11, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $1.05M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cherington CharlesCIK 0001448698 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2023 | Common Stock | PPurchaseAcquired | +2,053,789 | $0.51F1 | +$1,047,432.39 | 5,813,650 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2023 | Common Stock | PPurchaseAcquired | +5,134,474 | $0.00F1 | $0 | 5,134,474 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On September 11, 2023, pursuant to a private placement offering by the Issuer and following the receipt of stockholder approval, the Reporting Person acquired 2,053,789 shares of the Issuer's Common Stock and Warrants to purchase up to 5,134,474 shares of Common Stock. The combined purchase price per share of Common Stock and accompanying Warrant in the offering was $0.51125, with all of the purchase price allocated to the shares of Common Stock.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.